ARTEMISMEDBSEArtemis Medicare Services LtdHighPositive
Announced Fri, 8 May · 19:07 IST

Press Release - May 8, 2026

Pat Growth 25pctEbitda Margin ExpansionResults View source PDF

ARTEMISMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.5%1-day move
₹266.00
prior close
₹272.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.3+2.7+3.3+3.8+1.5+3.8+4.2+5.4+2.3+5.3+2.3-4.5+4.7
Up moveDown movePending
AI summary

Artemis Medicare Services reported strong Q4 FY26 consolidated results with revenue from operations of Rs 27,923 Lacs, up 16.4% YoY. EBITDA grew 23.1% to Rs 5,938 Lacs while PAT jumped 32.1% to Rs 3,028 Lacs. For the full year FY26, consolidated revenue was Rs 1,08,124 Lacs (up 15.4%), EBITDA Rs 21,801 Lacs (up 18.0%), and PAT Rs 10,372 Lacs (up 26.2%). The flagship Gurugram hospital showed ARPOB improvement to Rs 84,571 from Rs 78,835, with overseas patient revenue growing 13.5% to Rs 8,226 Lacs (30.8% contribution). Bed capacity utilisation was 64.6% for Q4. The company is expanding into Raipur to enter new high-growth markets.

Likely market impact

Strong quarter with PAT growth exceeding 32% and EBITDA margin expansion signals solid operational leverage. The company's focus on high-acuity care and medical value travel is driving above-industry growth, which is positive for shareholders.